Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
Clinical trial NCT00830414 · COMPLETED
Trial details
- NCT number
- NCT00830414
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2002-09-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.